Get started
Author

Gray Kueberuwa

Observed names: G. Kueberuwa, Kueberuwa, G., Kueberuwa, Gray, Kueberuwa, Gray L B
ORCID: 0000-0001-9066-0181
Observed ORCID: 0000-0001-9066-0181
OpenAlex ID: A5024924798
CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity
2017 · Gray Kueberuwa, Milena Kalaitsidou, et al. · Molecular Therapy — Oncolytics · 179
PDF
CAR T-cell Therapy: Toxicity and The Relevance of Preclinical Models
2015 · Milena Kalaitsidou, Gray Kueberuwa, et al. · Immunotherapy · 99
Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators
2016 · Arthur Dyer, Ying Di, et al. · Molecular Therapy — Oncolytics · 49
PDF
Impact of Polymer-TLR-7/8 Agonist (Adjuvant) Morphology on the Potency and Mechanism of CD8 T Cell Induction
2019 · Geoffrey M. Lynn, Petr Chytil, et al. · Biomacromolecules · 42
Large expert-curated database for benchmarking document similarity detection in biomedical literature search
2019 · Peter Brown, Aik-Choon Tan, et al. · Database · 40
PDF
Optogenetic control of iPS cell‐derived neurons in 2D and 3D culture systems using channelrhodopsin‐2 expression driven by the synapsin‐1 and calcium‐calmodulin kinase II promoters
2018 · Si‐Yuen Lee, Julian H. George, et al. · Journal of Tissue Engineering and Regenerative Medicine · 32
PDF
CCR7+ selected gene-modified T cells maintain a central memory phenotype and display enhanced persistence in peripheral blood in vivo
2017 · Gray Kueberuwa, Hannah Gornall, et al. · Journal for ImmunoTherapy of Cancer · 27
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
2018 · Gray Kueberuwa, Weiming Zheng, et al. · Journal of Visualized Experiments · 17
PDF
Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes
2023 · Milena Kalaitsidou, Owen R. Moon, et al. · Frontiers in Immunology · 14
Blood compatibility of enveloped viruses.
2010 · Gray Kueberuwa, Ryan Cawood, et al. · PubMed · 13
Transgenic T-cell receptor immunotherapy for cancer: building on clinical success
2020 · Natasha Oppermans, Gray Kueberuwa, et al. · Therapeutic Advances in Vaccines and Immunotherapy · 12
PDF
Tissue-Specific Attenuation of Oncolytic Sindbis Virus Without Compromised Genetic Stability
2014 · Gray Kueberuwa, Ryan Cawood, et al. · Human Gene Therapy Methods · 10
Clinical feasibility and treatment outcomes with nonselected autologous tumor-infiltrating lymphocyte therapy in patients with advanced cutaneous melanoma.
2022 · Manon Pillai, Yizhou Jiang, et al. · PubMed Central · 9
Engineering strategies to optimise adoptive cell therapy in ovarian cancer
2023 · Catarina Guerra, Milena Kalaitsidou, et al. · Cancer Treatment Reviews · 5
Antitumor activity of T cells expressing a novel anti-folate receptor alpha (FOLR1) costimulatory antigen receptor (CoStAR) in a human xenograft murine solid tumor model and implications for in-human studies.
2022 · Owen R. Moon, Yun Qu, et al. · Journal of Clinical Oncology · 4
198 Costimulatory antigen receptor (CoStAR): a novel platform that enhances the activity of tumor infiltrating lymphocytes (TILs)
2021 · Sujita Sukumaran, Milena Kalaitsidou, et al. · Regular and Young Investigator Award Abstracts · 4
PDF
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
2018 · Gray Kueberuwa, Weiming Zheng, et al. · Journal of Visualized Experiments · 3
Abstract LB150: Clinical Feasibility and Treatment Outcomes with Unselected Autologous Tumor Infiltrating Lymphocyte Therapy in Patients with Advanced Cutaneous Melanoma
2021 · Robert E. Hawkins, Yizhou Jiang, et al. · Cancer Research · 2
232 CARKey™ – a tri-specific, dual receptor, CAR T-cell therapy platform to overcome solid tumour antigen heterogeneity
2025 · Owen Moon, Jordan Hartley, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
426 Anti-folate receptor alpha (FRα) CoStimulatory Antigen Receptor (CoStAR™) drives distinct cytokine-mediated proliferation responses in CD4+ and CD8+ T cells
2023 · Martina Sykorova, Robert E Hawkins, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
282 Anti-folate receptor alpha (FRα) costimulatory antigen receptor (CoStAR) improves T-cell function across physiologically relevant ranges of FRα expression and T-cell receptor (TCR) affinities
2022 · Martina Sykorova, Michelle Mojadidi, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
199 Potent T cell costimulation mediated by a novel costimulatory antigen receptor (CoStAR) with dual CD28/CD40 signaling domains to improve adoptive cell therapies
2021 · Martina Sykorova, Leyuan Bao, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
1058P Treatment outcomes with unselected autologous tumor infiltrating lymphocytes (TILs) in patients (pts) with checkpoint inhibition–refractory advanced cutaneous melanoma
2021 · M. Pillai, R.E. Hawkins, et al. · Annals of Oncology · 1
PDF
Improving CAR T cell therapy to treat CD19+ malignancies
2017 · Gray Kueberuwa · Journal of Cancer Science & Therapy · 1
423 Single cell RNA sequencing reveals functionally validated signatures of cytotoxicity in anti-FRα CoStimulatory Antigen Receptor (CoStARTM) activated CD4+ T cells
2023 · Katrina Sherbina Baklan, Martina Sykorova, et al. · Regular and Young Investigator Award Abstracts
PDF
Works count: 34
Citation count: 567
H-index: 11
I10-index: 12
Year
Topic
Type